Arcedi Biotech Overview

  • Founded

  • 2013

Founded
  • Status

  • Private

  • Employees

  • 25

Employees
  • Latest Deal Type

  • Early Stage VC

  • Investors

  • 3

Arcedi Biotech General Information

Description

Operator of a biotechnology platform intended to provide a cell-based noninvasive prenatal diagnosis. The company's platform offers non-invasive prenatal diagnostic tests by analyzing the genome of the fetus using circulating fetal cells in maternal blood, enabling pregnant women to get accurate information about the genetic status of their unborn child.

Contact Information

Website
www.arcedi.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Primary Office
  • Tabletvej 1
  • 7100 Vejle
  • Denmark

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Arcedi Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Arcedi Biotech’s complete valuation and funding history, request access »

Arcedi Biotech Patents

  • 27

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 3

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Arcedi Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020289708-A1 Isolation of fetal cells using facs Pending 07-Jun-2019 00000000000
CA-3142663-A1 Isolation of fetal cells using facs Pending 07-Jun-2019 00000000000
EP-3980773-A1 Isolation of fetal cells using facs Pending 07-Jun-2019 00000000000
US-20210199664-A1 Isolation of fetal cells using facs Active 07-Jun-2019 00000000000
US-11573229-B2 Isolation of fetal cells using facs Active 07-Jun-2019 G01N33/56966 00
To view Arcedi Biotech’s complete patent history, request access »

Arcedi Biotech Executive Team (6)

Name Title Board Seat Contact Info
Palle Schelde Chief Executive Officer
John Riis Mortensen Chief Financial Officer
Inga Christensen Chief Operating Officer
Ripudaman Singh Ph.D Chief Technology Officer
Lotte Hatt Ph.D Chief Scientific Officer & Molecular Biologist
You’re viewing 5 of 6 executive team members. Get the full list »

Arcedi Biotech Board Members (4)

Name Representing Role Since
Claus Bagger-Sørensen Self Chairman 000 0000
Hans-Henrik Eriksen Vecata Invest Board Member 000 0000
Steen Bagger-Sørensen Vecata Invest Board Member 000 0000
Tonni Bülow-Nielsen Self Board Member 000 0000
To view Arcedi Biotech’s complete board members history, request access »

Arcedi Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Arcedi Biotech Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bagger-Sørensen Group Corporation Minority 000 0000 000000 0
INCUBA Accelerator/Incubator Minority 000 0000 000000 0
Vecata Invest Venture Capital Minority 000 0000 000000 0
To view Arcedi Biotech’s complete investors history, request access »

Ready to get started?

Request a free trial